Inflammation-associated regulation of the macrophage inhibitory cytokine (MIC-1) gene in prostate cancer

Oncology Letters

Volumn 3, Issue 5, 2012, Pages 1166-1170

  Dubey, Seema ^a   Vanveldhuizen, Peter ^b,c   Holzbeierlein, Jeffrey ^a   Tawfik, Ossama ^d   Brantley Thrasher, J ^a   Karan, Dev ^a,b  

^a UNIVERSITY OF KANSAS SCHOOL OF MEDICINE   (United States)

^b VETERANS AFFAIRS MEDICAL CENTER   (United States)

^c Division of Internal Medicine   (United States)

^d UNIVERSITY OF KANSAS MEDICAL CENTER   (United States)

Author keywords

Inflammation; Macrophage inhibitory cytokine 1; Prostate cancer

Indexed keywords

GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; GROWTH DIFFERENTIATION FACTOR 15; INTERLEUKIN 1BETA; INTERLEUKIN 6; PROSTATE SPECIFIC ANTIGEN; TUMOR NECROSIS FACTOR ALPHA;

AGED; ANIMAL TISSUE; ARTICLE; CARCINOGENESIS; CONTROLLED STUDY; DISEASE ASSOCIATION; GENE EXPRESSION; HUMAN; HUMAN CELL; IMMUNOREGULATION; LYMPHOCYTIC INFILTRATION; MALE; MOUSE; NONHUMAN; PROSTATE CANCER; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA ISOLATION; TRANSGENIC MOUSE; UPREGULATION;

EID: 84857944000     PISSN: 17921074     EISSN: 17921082     Source Type: Journal    
DOI: 10.3892/ol.2012.635     Document Type: Article

References (30)

1. Jemal A, Siegel R, Xu J and Ward E: Cancer statistics, 2010. CA Cancer J Clin 60: 277-300, 2010.
2. Karan D, Thrasher JB and Lubaroff D: Prostate cancer: genes, environment, immunity and the use of immunotherapy. Prostate Cancer Prostatic Dis 11: 230-236, 2008.
3. Pienta KJ and Esper PS: Risk factors for prostate cancer. Ann Intern Med 118: 793-803, 1993.
4. De Marzo AM, Platz EA, Sutcliffe S, et al: Inflammation in prostate carcinogenesis. Nat Rev Cancer 7: 256-269, 2007.
5. Platz EA and De Marzo AM: Epidemiology of inflammation and prostate cancer. J Urol 171: S36-S40, 2004.
6. Mantovani A, Allavena P, Sica A and Balkwill F: Cancer-related inflammation. Nature 454: 436-444, 2008.
7. Coussens LM and Werb Z: Inflammation and cancer. Nature 420: 860-867, 2002.
8. Wang D and Dubois RN: Prostaglandins and cancer. Gut 55: 115-122, 2006.
9. Bootcov MR, Bauskin AR, Valenzuela SM, et al: MIC-1, a novel macrophage inhibitory cytokine, is a divergent member of the TGF-beta superfamily. Proc Natl Acad Sci USA 94: 11514-11519, 1997.
10. Senapati S, Rachagani S, Chaudhary K, Johansson SL, Singh RK and Batra SK: Overexpression of macrophage inhibitory cytokine-1 induces metastasis of human prostate cancer cells through the FAK-RhoA signaling pathway. Oncogene 29: 1293-1302, 2010.
11. Breit SN, Johnen H, Cook AD, et al: The TGF-beta superfamily cytokine, MIC-1/GDF15: A pleotrophic cytokine with roles in inflammation, cancer and metabolism. Growth Factors 29: 187-195, 2011.
12. Cheung PK, Woolcock B, Adomat H, et al: Protein profiling of microdissected prostate tissue links growth differentiation factor 15 to prostate carcinogenesis. Cancer Res 64: 5929-5933, 2004.
13. Karan D, Chen SJ, Johansson SL, et al: Dysregulated expression of MIC-1/PDF in human prostate tumor cells. Biochem Biophys Res Commun 305: 598-604, 2003.
14. Brown DA, Bauskin AR, Fairlie WD, et al: Antibody-based approach to high-volume genotyping for MIC-1 polymorphism. Biotechniques 33: 118-120, 122, 124 passim, 2002.
15. Brown DA, Moore J, Johnen H, et al: Serum macrophage inhibitory cytokine 1 in rheumatoid arthritis: a potential marker of erosive joint destruction. Arthritis Rheum 56: 753-764, 2007.
16. Tong S, Marjono B, Brown DA, et al: Serum concentrations of macrophage inhibitory cytokine 1 (MIC 1) as a predictor of miscarriage. Lancet 363: 129-130, 2004.
17. Brown DA, Lindmark F, Stattin P, et al: Macrophage inhibitory cytokine 1: a new prognostic marker in prostate cancer. Clin Cancer Res, 2009.
18. Sun J, Turner A, Xu J, Gronberg H and Isaacs W: Genetic variability in inflammation pathways and prostate cancer risk. Urol Oncol 25: 250-259, 2007.
19. Selander KS, Brown DA, Sequeiros GB, et al: Serum macrophage inhibitory cytokine-1 concentrations correlate with the presence of prostate cancer bone metastases. Cancer Epidemiol Biomarkers Prev 16: 532-537, 2007.
20. Karan D, Holzbeierlein J and Thrasher JB: Macrophage inhibitory cytokine-1: possible bridge molecule of inflammation and prostate cancer. Cancer Res 69: 2-5, 2009.
21. Taniguchi S, Taoka R, Inui M, Sugimoto M and Kakehi Y: Influence of inflammation and aging on macrophage inhibitory cytokine-1 gene expression in rat ventral prostate. Urology 73: 410-414, 2009.
22. Albertoni M, Shaw PH, Nozaki M, et al: Anoxia induces macrophage inhibitory cytokine-1 (MIC-1) in glioblastoma cells independently of p53 and HIF-1. Oncogene 21: 4212-4219, 2002.
23. Bauskin AR, Jiang L, Luo XW, Wu L, Brown DA and Breit SN: The TGF-beta superfamily cytokine MIC-1/GDF15: secretory mechanisms facilitate creation of latent stromal stores. J Interferon Cytokine Res 30: 389-397, 2010.
24. Bauskin AR, Zhang HP, Fairlie WD, et al: The propeptide of macrophage inhibitory cytokine (MIC-1), a TGF-beta superfamily member, acts as a quality control determinant for correctly folded MIC-1. Embo J 19: 2212-2220, 2000.
25. Chen SJ, Karan D, Johansson SL, et al: Prostate-derived factor as a paracrine and autocrine factor for the proliferation of androgen receptor-positive human prostate cancer cells. Prostate 67: 557-571, 2007.
26. Van der Heul-Nieuwenhuijsen L, Hendriksen PJ, van der Kwast TH and Jenster G: Gene expression profiling of the human prostate zones. BJU Int 98: 886-897, 2006.
27. Paralkar VM, Vail AL, Grasser WA, et al: Cloning and characterization of a novel member of the transforming growth factor-beta/bone morphogenetic protein family. J Biol Chem 273: 13760-13767, 1998.
28. Bostwick DG, de la Roza G, Dundore P, Corica FA and Iczkowski KA: Intraepithelial and stromal lymphocytes in the normal human prostate. Prostate 55: 187-193, 2003.
29. Zimmers TA, Jin X, Hsiao EC, McGrath SA, Esquela AF and Koniaris LG: Growth differentiation factor-15/macrophage inhibitory cytokine-1 induction after kidney and lung injury. Shock 23: 543-548, 2005.
30. Zimmers TA, Jin X, Hsiao EC, et al: Growth differentiation factor-15: induction in liver injury through p53 and tumor necrosis factor-independent mechanisms. J Surg Res 130: 45-51, 2006.